Genetic pleiotropy differentially linking brain variation to cannabis use and cannabis use disorder

Since cannabis use (CU) has increased substantially worldwide, understanding the neurobiological mechanisms differentiating CU from cannabis use disorder (CUD) has important public health implications. Leveraging genome-wide data available from UK Biobank, International Cannabis Consortium, the Psychiatric Genomics Consortium, and the Million Veteran Program, we characterized the pleiotropy differentially linking brain structural and functional variation to CU and CUD. Specifically, we conducted linkage disequilibrium score regression, local analysis of [co]variant association, and latent causal variable analysis. Distinct patterns of global genetic correlations were observed, where CU was specifically related to default mode network-related functional activity and the functional connectivity between default mode and central executive networks, while CUD was related to functional connectivity linking default mode and salience networks and with white matter microstructure. Latent causal variable analyses suggested partial genetic causality differentially linking the functional connectivity among salience, default mode, and central executive networks to CU and CUD. Local genetic correlation analyses further identified CU and CUD-specific shared genetic architecture with brain variation related to genes involved in neurodevelopment, chromatin regulation, synaptic signaling, and white matter biology. Through gene-set enrichment analyses, we identified pathways related to brain variation converging on inflammatory response and cell activation for CU, and on cellular stress-response and immune regulation for CUD. Applying gene2drug framework, our drug-repurposing analyses identified nine molecular compounds, also including raloxifene (a cannabinoid-receptor 2 inverse agonist) and albendazole (reported to interact with cannabis smoking). Overall, these findings provide new insights into the neurobiological pathways underlying CU and its progression to CUD.

Authors

Institutions

Publication Details

Journal
Neuropsychopharmacology
Published
2026-07-30
DOI
https://doi.org/10.1038/s41386-026-02506-y
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genetic pleiotropy differentially linking brain variation to cannabis use and cannabis use disorder

Huaigui Liu, Brenda Cabrera‐Mendoza, Qianyu Chen, Renato A Polimanti et al.
Neuropsychopharmacology
Cannabis and Cannabinoid Research
article

Genetic pleiotropy differentially linking brain variation to cannabis use and cannabis use disorder

Huaigui Liu, Brenda Cabrera‐Mendoza, Qianyu Chen, Renato A Polimanti, Jun He, Dan Qiu, Zhongzheng Mao, Ziang Xu
article en

Abstract

Since cannabis use (CU) has increased substantially worldwide, understanding the neurobiological mechanisms differentiating CU from cannabis use disorder (CUD) has important public health implications. Leveraging genome-wide data available from UK Biobank, International Cannabis Consortium, the Psychiatric Genomics Consortium, and the Million Veteran Program, we characterized the pleiotropy differentially linking brain structural and functional variation to CU and CUD. Specifically, we conducted linkage disequilibrium score regression, local analysis of [co]variant association, and latent causal variable analysis. Distinct patterns of global genetic correlations were observed, where CU was specifically related to default mode network-related functional activity and the functional connectivity between default mode and central executive networks, while CUD was related to functional connectivity linking default mode and salience networks and with white matter microstructure. Latent causal variable analyses suggested partial genetic causality differentially linking the functional connectivity among salience, default mode, and central executive networks to CU and CUD. Local genetic correlation analyses further identified CU and CUD-specific shared genetic architecture with brain variation related to genes involved in neurodevelopment, chromatin regulation, synaptic signaling, and white matter biology. Through gene-set enrichment analyses, we identified pathways related to brain variation converging on inflammatory response and cell activation for CU, and on cellular stress-response and immune regulation for CUD. Applying gene2drug framework, our drug-repurposing analyses identified nine molecular compounds, also including raloxifene (a cannabinoid-receptor 2 inverse agonist) and albendazole (reported to interact with cannabis smoking). Overall, these findings provide new insights into the neurobiological pathways underlying CU and its progression to CUD.

Neuropsychopharmacology
University of Connecticut (US), Tianjin Medical University General Hospital (CN), Yale University (US), VA Connecticut Healthcare System (US)
American Foundation for Suicide Prevention
Good health and well-being
Openalex Percentile: Top 11%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.